Axitinib
Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM in Porcine aorta endothelial cells, respectively.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S1005 |
| Sku # | S1005-50mg |
| Pricing | 50mg, $70.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2020Quote: Cell viability of cultures treated for 48 hours with 5µM axitinib (Selleck Chemicals S1005), Cabozantinib (Selleck Chemicals S1119) ...
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were treated the next day with 5 µM axitinib (Selleck Chemicals S1005), a combination of etoposide (Selleck Chemicals S1225 ...
-
bioRxiv - Cancer Biology 2020Quote: ... or treated with both 50 µg/mL MDA-MB-231-HEXOs and 0.1 µM Axitinib (Selleck Chemicals, Cat No. S1005). After 24 h ...